Hemostatic effect of oxidized regenerated cellulose in an experimental gastric mucosal resection model

Background and study aim: The endoscopic hemostatic therapies currently available do not always result in hemostasis of gastrointestinal bleeding. Oxidized regenerated cellulose (ORC) mesh is a widely available surgical hemostatic material. The aim of this study was to evaluate the hemostatic efficacy of ORC in experimental gastric hemorrhage after endoscopic resection.

Methods: This was a prospective, two-stage experimental, Phase I, proof-of-concept study. In Stage 1, eight gastric mucosal lesions were created in anticoagulated rabbits and treated with ORC (closed or open pores). In Stage 2, the endoscopic introduction and application of ORC mesh pieces were evaluated in a porcine model of endoscopic submucosal dissection (ESD).

Results: In Stage 1, hemostasis was achieved in all lesions. Hemostasis was achieved more rapidly with closed-pore than open-pore ORC (24.5 vs. 66.5 seconds) (P < 0.01). At 24 hours, all lesions showed persistent hemostasis. There were no episodes of rebleeding, complications, or mortality. In Stage 2, the endoscopic introduction of ORC pieces and application with a biopsy forceps were feasible in all ESD lesions.

Conclusions: ORC was an effective hemostatic agent for bleeding lesions following mucosal resection in anticoagulated rabbits. Closed-pore ORC achieved hemostasis faster than open-pore ORC. Endoscopic introduction and release of ORC were feasible.

• References

• 1 Aabakken L. Current endoscopic and pharmacological therapy of peptic ulcer bleeding. Best Pract Res Clin Gastroenterol 2008; 22: 243-259
• 2 Marek TA. Gastrointestinal bleeding. Endoscopy 2011; 43: 971-977
• 3 Millat B, Hay JM, Valeur P et al. Emergency surgical treatment for bleeding duodenal ulcer: oversewing plus vagotomy and gastric resection, a controlled randomised trial. World J Surg 1993; 17: 568-574
• 4 Veitch AM, Baglin TP, Gershlick AH. British Society of Gastroenterology, British Committee for Standards in Haematology, British Cardiovascular Intervention Society et al. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008; 57: 1322-1329
• 5 Lee SJ, Shin DH, Hwang HJ et al. Bleeding risk and major adverse events in patients with previous ulcer on oral anticoagulation therapy. Am J Cardiol 2012; 110: 373-377
• 6 Hallas J, Dall M, Andries A et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006; 333: 726
• 7 Fujishiro M, Oda I, Yamamoto Y et al. Multi-center survey regarding the management of anticoagulation and antiplatelet therapy for endoscopic procedures in Japan. J Gastroenterol Hepatol 2009; 24: 214-218
• 8 Anastassiades CP, Baron TH, Wong Kee Song LM. Endoscopic clipping for the management of gastrointestinal bleeding. Nat Clin Pract Gastroenterol Hepatol 2008; 5: 559-568
• 9 Pescatore P, Jornod P, Borovicka J et al. Epinephrine versus epinephrine plus fibrin glue injection in peptic ulcer bleeding: a prospective randomized trial. Gastrointest Endosc 2002; 55: 348-353
• 10 Holster IL, Kuipers EJ, Tjwa ET. Hemospray in the treatment of upper gastrointestinal hemorrhage in patients on antithrombotic therapy. Endoscopy 2013; 45: 63-71
• 11 Spangler D, Rothenburger S, Nguyen K et al. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. Surg Infect 2003; 4: 255-262
• 12 Spotnitz WD. Active and mechanical hemostatic agents. Surgery 2007; 142: 34-S38
• 13 Behrens AM, Sikorski MJ, Kofinas P. Hemostatic strategies for traumatic and surgical bleeding. J Biomed Mater Res A 2013; [Epub ahead of print]
• 14 Samudrala S. Topical hemostatic agents in surgery: a surgeon’s perspective. AORN J 2008; 88: 2-S11
• 15 Wang H, Chen P. Surgicel^® (oxidized regenerated cellulose) granuloma mimicking local recurrent gastrointestinal stromal tumor: a case report. Oncol Lett 2013; 5: 1497-1500